Dana Farber Cancer Institute, Inc.;Acetylon Pharmaceuticals, Inc.
发明人:
WONG, Kwok-kin,LIU, Yan,ADEEGBE, Dennis, O.,QUAYLE, Steven, Norman
申请号：
EP17811118
公开号：
EP3468559A4
申请日:
2017.06.09
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The disclosure relates to pharmaceutical combinations comprising an HDAC6 selective inhibitor and a BET inhibitor for the treatment of cancer in a subject in need thereof. Also provided herein are methods for treating cancer in a subject in need thereof, comprising administering to the subject an effective amount of an HDAC6 selective inhibitor and a BET inhibitor.
